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Abstract.  Extracts of the electric organ of Torpedo 
californica contain a proteinaceous factor that causes 
the formation of patches on cultured myotubes at 
which acetylcholine receptors (AChR), acetylcholines- 
terase (ACHE), and butyrylcholinesterase (BuChE) are 
concentrated. Results of previous experiments indicate 
that this factor is similar to the molecules in the syn- 
aptic basal lamina that direct the aggregation of AChR 
and AChE at regenerating neuromuscular junctions in 
vivo.  We have purified the active components in the 
extracts 9,000-fold.  mAbs against four different epi- 
topes on the AChR/AChE/BuChE-aggregating mole- 
cules each immunoprecipitated four polypeptides from 
electric organ extracts, with molecular masses of 150, 
135, 95,  and 70 kD.  Gel filtration chromatography of 
electric organ extracts revealed tw~ peaks of AChR/ 
AChE/BuChE-aggregating activity; one comigrated 
with the 150-kD polypeptide, the other with the 95-kD 
polypeptide. The 135- and 70-kD  polypeptides did not 
cause AChR/AChE/BuChE aggregation. Based on 
these molecular characteristics and on the pattern of 
staining seen in sections of muscle labeled with the 
mAbs, we conclude that the electric organ-aggregating 
factor is distinct from previously identified molecules, 
and we have named it "agrin: 
F 
INDINGS from studies  conducted  in this  laboratory 
have led to the hypothesis that a proteinaceous factor 
extracted from the synapse-rich electric organ of Tor- 
pedo californica (15, 16, 29, 34, 45) resembles the extracellu- 
lar synaptic organizing molecules in the basal lamina at the 
neuromuscular junction that direct the formation of acetyl- 
choline receptor (AChR)  1 and acetylcholinesterase  (ACHE) 
aggregates on regenerating muscle fibers (4, 25). For exam- 
ple, the factor is found in basal lamina-containing  fractions 
of the electric organ; it induces the formation of patches on 
cultured muscle fibers that contain a high concentration of 
AChRs and ACHE; low levels of a similar factor are found 
in extracts of muscle; and mAbs against the factor recognize 
molecules concentrated in the synaptic cleft of neuromuscu- 
lar junctions in vivo. Patches induced by the electric organ 
factor also include butyrylcholinesterase  (BuChE),  a third 
component of the postsynaptic apparatus at the neuromuscu- 
lar junction (43). It may well be that the factor is capable of 
triggering the formation of a complete postsynaptic appara- 
tus (43, 45). 
We have now made additional mAbs against the electric 
organ factor. As described in the accompanying report,  we 
have shown that these antibodies bind to components of the 
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synaptic basal lamina at the neuromuscular junction, provid- 
ing further evidence that the electric organ factor resembles 
the  AChR/AChE-aggregating  molecules  in  the  synaptic 
basal lamina. The aims of the studies described here were 
to use these mAbs to identify the electric organ factor. On 
the basis of its biochemical properties  and the distribution 
of anti-agrin staining in muscles, we conclude that the elec- 
tric organ  AChR/AChE/BuChE-aggregating  factor differs 
from previously identified AChR-aggregating molecules and 
identified components of the synaptic cleft at the neuromus- 
cular junction. Therefore, we name the AChR/AChE/BuChE- 
aggregating factor in our extracts of electric organ "agrin" 
(from the Greek "ageirein; to assemble).  Brief accounts of 
some of these results have been reported previously (22, 29, 
40). 
Materials and Methods 
Acetylcholine Receptor-, Acetylcholinesterase-,  and 
Butyrylcholinesterase-aggregating  Activity 
The assay for AChR-aggregating activity has been described in detail (16). 
In brief, 4-7-d-old cultures of  chick myotubes were exposed to test solutions 
for 12-18 h, incubated for 1 h at 37~  with 10  -s M rhodamine-a-bungaro- 
toxin to label AChRs, rinsed with Puck's saline, fixed for 10 rain at -20~ 
in 95 % ethanol, mounted in glycerol, and examined by fluorescence micros- 
copy. The level of AChR-aggregating activity in a sample was determined 
by counting the mean number of AChR aggregates per field (or per myotube 
segment). AChR-aggregating activity is expressed in units;  1 U of AChR- 
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ACHE- and BuCHE-aggregating  activities were assayed as previously de- 
scribed (43). In brief, cultures were treated with extracts and labeled with 
rhodamine-tt-bungarotoxin as described above,  fixed with  1%  parafor- 
maldehyde, and labeled with a mAb against chick ACHE (35) followed by 
fluorescein-conjugated second antibody, or stained histochemically for sites 
of BuChE activity.  Cultures were examined by phase and fluorescence mi- 
croscopy and the levels of ACHE- and BuChE-aggregating activity were de- 
termined by the same method as for AChR-aggregating activity. 
Protein Assay 
Protein concentration was determined by the method of Bradford (11), using 
BSA as the standard. 
Extraction-and Purification 
An insoluble fraction enriched in extracellular matrix components was pre- 
pared by extracting homogenates of electric organ with isotonic saline and 
detergent at  pH  7.5  (16).  The  insoluble fraction was  resuspended and 
homogenized in bicarbonate buffer (0.2 M  sodium bicarbonate, 5% glyc- 
erol, 0.02 % sodium azide, pH 9.0 [300 ml/kg of electric organ]), stirred 
overnight at 4~  rehomogenized, and centrifuged (30,000  g; 20 rain). In 
some experiments, the pellet was reextraeted in the same manner and the 
superuatants were combined. 
The supernatant was applied to a 9-ml column of Cibacron Blue 3GA- 
agarose (Afli-gel Blue Gel,  100-200  mesh [Bio-Rad Laboratories, Rich- 
mond, CA]) equilibrated in bicarbonate buffer.  The column was washed 
with 20 ml of bicarbonate buffer and eluted with a 40-ml linear gradient 
of 0-3 M NaCI in bicarbonate buffer,  followed by 20 ml of 3 M NaCI. In 
some experiments, the supernatant was loaded onto a 25-ml column of  Ciha- 
cron Blue 3GA-agarose, washed with 10 column volumes of bicarbonate 
buffer, and eluted with 30 ml of 1.5 M NaCI in bicarbonate buffer. Fractions 
with the highest specific activity were pooled. 
An aliquot of the pooled fractions was applied to either a 540-ml column 
(110 ￿  2.5 cm) of Bio-Gel A 1.5m agarose (Bio-Rad Laboratories) or a 94- 
ml (120 x  1 cm) column of Sephacryl S-200 (Pharmacia Fine Chemicals, 
Piscataway,  NJ) equilibrated and eluted with bicarbonate buffer containing 
0.5 M NaCI. Columns were calibrated with Blue Dextran (>1000 kD =  void 
volume  [Pharmacia  Fine Chemicals]),  ~galactosidase (540  kD  [Sigma 
Chemical Co., St. Louis, MO]), glucose 6-phosphate dehydrogenase (104 
kD [Sigma Chemical Co.]), BSA (66 kD [Sigma Chemical Co.]), ovaibu- 
min (43  kD  [Sigma Chemical Co.]), and cytochrome c  (12.4 kD [Sigma 
Chemical Co.]). Fractions from the Bio-Gel A  1.5m agarose column with 
highest specific activity were pooled and concentrated 5-10-fold by vacuum 
dialysis against a phosphate buffer (10 mM sodium phosphate, 5 % glycerol, 
0.02 % sodium azide, pH 8.0). 
The concentrated gel filtration pool was applied to a  1-ml column of 
DEAE cellulose (Whatman Inc., Clifton, NJ) equilibrated in phosphate 
buffer. After washing with 5 column volumes of  phosphate buffer, the bound 
material was eluted with a 10-ml linear gradient of  0-250 mM NaCI in phos- 
phate buffer. 
Radiolabeling  of  Proteins 
Proteins eluted from the ion exchange column were covalently labeled with 
radioactive iodine by a solid-phase method (23). Briefly,  1-50 txg of protein 
(corresponding to 200 U of activity) were reacted with 1 mCi of ~25I-sodi- 
um iodide (Amersham Corp., Arlington Heights, IL) in the presence of 
2  I.tg  of immobilized IODO-GEN (Pierce Chemical Co., Rockford, IL). Af- 
ter 20-30 rain free iodide was separated from the protein by gel filtration 
on a  small column of Sephadex G-25  (PD-10  column  [Pharmacia Fine 
Chemicals]). 
lmmunoprecipitation 
Aliquots of ~2~I-labeled  ion exchange pool ('~107 cpm) were incubated with 
0.05 ml of either a test hybridoma supernatant, a control hybridoma super- 
natant, or normal mouse serum in PBS-GS (150 mM NaCI, 5 % glycerol, 
0.5% NP-40 [Sigma Chemical Co.],  10% goat serum, in 50 mM sodium 
phosphate buffer, pH 7.0). ARer 2 h at room temperature, 10 Ixl of Sepharose 
beads (Sepharose CL-4B-200 [Sigma Chemical Co.]) to which goat anti- 
mouse IgG (Antibodies, Inc., Davis, CA) had been covalently coupled (16) 
were added. After an additional  1-h incubation at room temperature the 
beads were washed three times in 1 ml PBS-GS, then boiled for 5 min in 
50 lal of SDS sample buffer.  Material eluted by this treatment was analyzed 
by SDS-PAGE (18) and autoradiography. Parallel experiments demonstrated 
that under these conditions mAbs against the AChR/AChE/BuChE-aggre- 
gating factor removed virtually all aggregating activity from solution. 
Immunoblotting 
Samples were subjected to electrophoresis on an SDS-polyacrylamide gel 
and electrophoretically transferred onto nitrocellulose paper after the meth- 
od of Towbin et al. (41). The paper was washed four times for 15 min each 
time in PBSA-T (150 mM sodium chloride, 0.02%  sodium azide, 0.05% 
Tween-20, in 50 mM sodium phosphate buffer, pH 7.5),  blocked for 2-3 h 
in PBSA-T containing 0.1% goat serum and 3% BSA, and then incubated 
overnight in undiluted hybridoma supernatant, or a  1:1,000 dilution of as- 
cites or normal mouse IgG in hybridoma growth medium containing 0.05 % 
Tween-20. The paper was washed four times for 15 min each time in PBSA-T 
containing goat serum, incubated for 4 h with alkaline phosphatase-coupled 
goat anti-mouse immunoglobulin (Kirkegaard & Perry Laboratories, Inc., 
Gaithersburg, MD) diluted 1:1,000 in PBSA-T containing 0.1% normal goat 
serum, rinsed four times for 15 min each time in PBSA-T, and reacted for 
alkaline phosphatase activity.  This procedure allowed detection of <200 U 
of AChR-aggregating activity. 
lmmunoaJJinity Purification 
Normal mouse IgG or mAbs from hybridoma supernatants or ascites fluid 
were covalently coupled to protein A-Sepharose CL-4B (Pharmacia Fine 
Chemicals) by the method of Schneider et at. (39). Aliquots of  the Cihacron 
pool (3,000 U) were incubated overnight at 4~  with gentle agitation with 
10-50 ~tl of mAb or normal mouse IgG beads. The beads were washed se- 
quentially in 100 vol each of 10 mM triethanolamine buffer, pH 8.2, contain- 
ing 150 mM NaCI, 0.5% NP-40, and 5% glycerol (wash buffer); triethanol- 
amine buffer containing 1 M NaCI, 0.5%  NP-40,  and 5% glycerol; wash 
buffer; triethanolamine buffer containing 150 mM NaCI, 5% glycerol, and 
0.5% sodium deoxycholate; and wash buffer. After washing, the beads were 
eluted with 2 x  0.5-ml of 50 mM triethylamine, pH 11.5, containing 150 mM 
NaCI, 5% glycerol, and 0.5% NP-40. The elnates were pooled and proteins 
were precipitated with 20% TCA, washed three times with 0.6 ml acetone 
at 4~  separated by SDS-PAGE, and visualized by silver staining (27). Un- 
der these conditions, >75%  of the activity present in the extract bound to 
the antibody beads. 
Results 
As a  first step  toward purifying the AChR/AChE/BuChE- 
aggregating factor agrin from homogenates of the electric 
organ of Torpedo californica, we isolated material that is 
insoluble in  isotonic saline and detergent at neutral pH. 
Table L Purification  of  AChR-aggregating Activity  from 
Torpedo Electric Organ 
AChR- 
aggregating 
Fraction  Protein  activity  Purification  Yield 
rag  U  fold 
Electric organ 
homogenate  14,000  845,000  1  100 
Insoluble fraction  2,700  760,000  5  90 
pH 9  bicarbonate 
extract  545  695,000  22  82 
Cibacron pool  9.0  380,000  715  45 
Gel filtration pool  1.2  230,000  3,300  28 
Ion exchange pool  0.070  36,000  8,800  4 
AChR-aggregating  activity was purified from 1.33 kg (wet weight) of Torpedo 
californica electric organ by procedures described in Materials and Methods. 
Values listed above were typical;  other preparations  generally  were within a 
factor of three with respect to purification  and yield. 
The Journal  of Cell Biology,  Volume 105, 1987  2472 ELUTED  VOLUME  (ml) 
1400 
1200 
I000  '~ 
soo  3. 









20  ~" 
Figure 1. Affinity chromatography on Cibacron Blue 3GA-agarose. 
Bicarbonate extract (545 mg protein; 695,000 U) was applied (80 
ml/h) to a 9-ml column of Cibacron Blue 3GA-Agarose; •65%  of 
the protein and 4%  of the activity were recovered in the flow- 
through volume. The column was washed with bicarbonate buffer 
(20 ml). Shown above is the elution of the column (40 ml/h) with 
a 40-ml linear gradient of 0--3 M NaC1 followed by 20 rnl of 3 M 
NaCI; fractions were assayed for AChR-aggregating activity (cir- 
cles) and  protein  concentration  (triangles). Material  eluting  at 
0.3-1.1 M NaCI (indicated by horizontal bar) was combined as the 
Cibacron pool; it accounted for 54 % of the applied activity, 2 % of 
the applied protein. 
Preparation and characterization of  the insoluble fraction has 
been described in detail elsewhere (16). 
Alkaline Extraction and AJ~nity Chromatography 
Agrin was solubilized by homogenizing the insoluble frac- 
tion in bicarbonate buffered saline, pH 9.0 (Table I). The bi- 
carbonate extract was applied to a column of Cibacron Blue 
3GA-Agarose. Most (I>95 %) of the AChR-aggregating activ- 
ity bound to the column while *65 % of the protein in the 
extract passed through. The column was eluted with a 0-3-M 
gradient of NaCI; agrin eluted together with the major peak 
of protein at '~0.5  M  NaCI  (Fig.  1).  Aliquots having the 
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Figure 2.  Gel filtration on Bio-Gel agarose 1.5m. Cibacron pool 
(16.5 ml; 9.0 mg protein; 377,000 U) was fractionated on a 540-ml 
(110 x 2.5-cm) column of Bio-Gel A 1.5m eluted at 50 ml/h. Frac- 
tions (12 ml) were assayed in triplicate for activity (circles) and in 
duplicate for protein concentration (triangles). The horizontal bar 
indicates the fractions combined to give the "gel filtration pool"; it 
contained 62 % of the applied activity, 14 % of the protein. Arrow 
indicates the position of the void volume. 
Gel Filtration Chromatography 
The Cibacron pool was fractionated by gel filtration chroma- 
tography on a Bio-Rad 1.5m agarose column. Much of the 
protein eluted in the void volume (Fig. 2), as is characteristic 
of  the large molecules expected in an extracellular matrix ex- 
tract. The major portion (,v62%) of the AChR-aggregating 
activity applied to the column eluted as a single peak in the 
included volume at a  position characteristic of a  globular 
protein with a molecular mass of  98 +  17 kD (mean +  SEM; 
n  =  3). In some preparations an additional, smaller peak of 
activity was observed at a position corresponding to higher 
molecular mass proteins (see reference 29). Fractions com- 
prising the major peak of activity were combined ("gel filtra- 
tion pooF) and concentrated by vacuum dialysis.  Due to 
precipitation from solution and/or adsorption of protein to 
the dialysis tubing, 50-75 % of the protein and AChR-aggre- 
gating activity were lost at this step. 
Ion Exchange Chromatography 
The dialyzed gel filtration pool was fractionated by ion ex- 
change chromatography on DEAE-cellulose at pH 8.0. More 
than 80 % of the activity initially bound to the resin while 
>70 % of the protein passed through (Fig. 3). The column 
was  eluted with a  linear gradient of 0-250 mM NaCI.  A 
broad peak of AChR-aggregating  activity (comprising ~40 % 
of the applied activity) and protein (~6%  of that applied) 
eluted between 55 and 90 mM NaC1 (Fig. 3). Fractions hav- 
ing the highest  specific activity were combined ("ion ex- 
change pool"). 
The purification protocol outlined above is summarized in 
Table I.  Purifications of several thousand-fold were rou- 
tinely obtained; the overall yield was low. Analysis of the ion 
exchange pool by SDS-PAGE (Fig. 4) revealed that it was far 
from homogeneous. In fact, in spite of the high specific ac- 
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Figure 3. Ion exchange chromatography on DEAE-cellulose. Dia- 
lyzed gel filtration pool (1.2 mg protein;  89,000 L0 was applied 
(5-10 ml/h) to a l-ml DEAE cellulose column. About 78 % of the 
protein and 3% of the activity passed through the column. The 
column was washed (5 ml) in phosphate buffer. Shown above is the 
elution of the column with a 10-ml linear gradient of 0-250 mM 
NaC1. Fractions were collected and assayed in duplicate for AChR- 
aggregating activity (circles) and protein concentration (triangles). 
Fractions eluting between 55 and 90 mM NaC1 (indicated by the 
horizontal bar) were combined to give the ion exchange pool. It 
contained 40% of the applied activity, 6% of the protein. 
Nitkin ct al. Agrin  2473 Figure 4. mAbs against AChR-aggregating  activity immunoprecipi- 
tate polypeptides of 95 and 70 kD. All lanes represent proteins sub- 
jected to electrophoresis through a 7.5% polyacrylamide-SDS gel. 
(a) Silver stain of 0.4 l~g (80 U) of a radiolabeled preparation of 
the ion exchange  pool. (b-h) Autoradiogram ofpolypeptides immu- 
noprecipitated from the radiolabeled ion exchange pool by (b) a 
control mAb and (c-h) mAbs that immunoprecipitate AChR-aggre- 
gating activity. Based on their properties as immunohistochemical 
reagents, each mAb (3B5, 4B1, 5BI, llD2, 2F6, and 17A6) recog- 
nizes a different epitope (see reference 34). (i and j) Immunoblot 
of aliquots of the gel filtration pool (3.7 p.g, 200 U) probed with (i) 
a control mAb and (j) mAb I1D2. 
a  relatively minor  component of this  pool,  as  discussed 
below. 
Identification of  Agrin Polypeptides 
To characterize further the components in our electric organ 
extracts that mediate AChR, ACHE, and BuChE aggregation, 
we raised a library of mAbs directed against antigens in the 
ion exchange pool (15, 34). Thirteen antibodies were selected 
for their ability to immunoprecipitate AChR-aggregating ac- 
tivity from electric organ extracts. Based on sensitivity to 
fixation and cross-reactivity in frog and/or chicken, these an- 
tibodies recognize at least seven different epitopes (34). 
We next sought to identify the polypeptides in our extracts 
to which the mAbs bound. In initial experiments we radiola- 
beled proteins in the ion exchange pool and immunoprecipi- 
rated them with mAbs that immunoprecipitate AChR-aggre- 
gating activity, mAbs recognizing six different epitopes each 
specifically precipitated polypeptides with apparent molecu- 
lar masses of 95 and 70 kD (Fig. 4). Although the relative 
amounts  of the  two  polypeptides  varied  somewhat  from 
preparation to preparation,  in each case most of the label 
was associated with the 95-kD polypeptide. In other experi- 
ments, an aliquot of the ion exchange pool was subjected to 
electrophoresis on an SDS-polyacrylamide gel, transferred 
to nitrocellulose paper, and immunoblotted. Only one of the 
13 mAbs bound to the immunoblots; it again stained poly- 
peptides of 95 and 70 kD (Fig. 4). These results indicate that 
either or both of the polypeptides (95 and 70 kD) is agrin. 
As mentioned above, AChR-aggregating activity was not 
always confined to a  single peak on gel  filtration column 
chromatography (e.g., reference 29). However, in our previ- 
ous immunoprecipitation experiments mAbs removed all of 
the  AChR/AChE/BuChE-aggregating  activity,  even  from 
relatively crude extracts such as the Cibacron pool (15, 43, 
45). Therefore, we were concerned that AChR/AChE/BuChE- 
aggregating molecules related to those in the ion exchange 
pool might be present in cruder fractions but excluded by the 
conventional chromatographic purification protocol. To in- 
vestigate this possibility we immunoaffinity purified proteins 
from the Cibacron pool and analyzed them by SDS-PAGE 
and silver staining.  Fig. 5 shows that five mAbs recognizing at 
least four different epitopes each immunoprecipitated AChR-, 
ACHE-, and BuChE-aggregating activities from the Cibacron 
pool. Silver stains of  the gels confirmed that the mAbs bound 
polypeptides of 70 and 95 kD, but in addition demonstrated 
that each mAb specifically immunoprecipitated polypeptides 
of 135 and 150 kD as well (Fig. 6). Thus, polypeptides of 150, 
135, 95, and 70 kD are specifically immunoprecipitated from 
crude extracts of  electric organ by mAbs that immunoprecip- 
itate AChR/AChE/BuChE-aggregating activity. 
Recent  immunohistochemical  studies  have  shown  that 
mAbs that immunoprecipitate agrin from extracts of Torpedo 
electric organ not only bind in high concentration at the neu- 
romuscular junction, but also recognize molecules at other 
sites in muscle (15, 34). This raises the possibility that one 
or more of the polypeptides immunoprecipitated by the mAbs 
might not cause AChR/AChE/BuChE aggregation. Alterna- 
tively, different aggregating activities might reside in differ- 
ent polypeptides. To investigate these possibilities, an aliquot 
of the Cibacron pool was fractionated on a Sephacryl S-200 
column and samples of  the fractions were analyzed by immu- 
noblotting and assayed for AChR-,  ACHE-, and BuChE-ag- 
gregating activities to correlate activity with the distribution 
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[] BuChE 
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Figure 5. Immunoprecipitation of AChR/AChE/BuChE-aggregat- 
ing activities. An aliquot of  the Cibacron pool (62 U) was combined 
with 5 Ixl of Sepharose beads carrying mAbs or normal mouse se- 
rum in 50 Ixl of culture medium. After incubation for 2 h at 37~ 
with constant gentle agitation, the beads were removed by centrifu- 
gation and the supernatants tested for residual AChR-, ACHE-, and 
BuChE-aggregating activities. Each of five different mAbs, recog- 
nizing at least four different epitopes, bound >75 % of all three ac- 
tivities. Data, expressed as mean +  SEM (n =  3), is normalized 
to the level of activity in extracts exposed to normal mouse se- 
rum-coupled beads. 
The Journal  of  Cell  Biology, Volume  105,  1987  2474 Figure 6. Antibodies against agrin bind to polypeptides of 150, 135, 
95, and 70 kD. Photograph of a silver-stained  SDS-polyacrylamide 
gel.  (a) 30 U Cibacron pool; (b-e) peptides  equivalent to 3,000 U, 
eluted  from (b)  normal mouse serum or (c-e) anti-agrin mAb- 
coupled beads (mAbs 6D4, liD2, and 5B1). Numbers at the left in- 
dicate positions  of molecular mass standards  (kD); arrows indicate 
positions of  the 150-, 135-, 95-, and 70-kD polypeptides consistently 
immunoprecipitated  by all  mAbs.  Similar  results  were obtained 
with two other mAbs (3B5, 13C5) recognizing at least  1 additional 
epitope (data not shown). 
of the  150-,  135-,  95-,  and 70-kD polypeptides.  As can be 
seen  in Fig.  7,  the peaks  of AChR-,  ACHE-,  and  BuChE- 
aggregating activity comigrate.  Comparison of the activity 
profile  with  the distribution  of polypeptides  bound by the 
anti-agrin mAb indicates that the 150- and 95-kD polypep- 
tides are responsible for the aggregating activities, while the 
135- and 70-kD polypeptides are inactive. In addition, under 
the buffer conditions in which the column was run, each of 
the four polypeptides appears  to migrate  independently  of 
the others as a monomeric protein.  Thus, we conclude that 
our extracts of electric organ contain two forms of agrin (150 
and 95 kD) and two inactive proteins that are antigenically 
related  to agrin. 
Discussion 
Molecules in the basal lamina at the neuromuscular junction 
direct the accumulation of  AChRs and AChE at synaptic sites 
on regenerating muscle fibers (4, 25). In an effort to identify 
these  molecules  we  have  purified  and  characterized  two 
proteins  from an extracellular  matrix-enriched  fraction of 
Torpedo electric  organ that each cause AChR,  ACHE, and 
BuChE aggregation in vitro. Results of previous studies (15, 
16,  29,  45)  and those reported  in the accompanying paper 
(34)  provide  evidence  that  these  proteins,  which  we  call 
agrin,  resemble the AChR/AChE-aggregating molecules in 
the synaptic basal lamina at the neuromuscular junction. 
We chose the electric organ of Torpedo as a  source from 
which to purify synaptic organizing molecules because the 
electric organ is densely innervated and has been useful for 
isolating and characterizing other components of cholinergic 
synapses,  such as AChRs and ACHE. The first step in our 
Figure  7.  AChR/AChE/BuChE-aggregating  ac- 
tivities  comigrate with polypeptides of 150  and 
95 kD. (Bottom) An aliquot of the Cibacron pool 
(0.75 ml,  9,000  U) was fractionated  on a  120  x 
1-cm column of Sephacryl S-200 (void volume = 
28 ml).  1-ml fractions were collected  and assayed 
for AChR-,  ACHE-, and BuChE-aggregating  ac- 
tivities.  The data is expressed  as mean  +  SEM 
(n =  3). (Top) A photograph of an immunoblot in 
which an 0.5-ml aliquot of each column fraction 
was treated  with TCA,  and the precipitated  pro- 
teins were separated by SDS-PAGE, transferred  to 
nitrocellulose,  and probed with mAb llD2.  The 
tv~ peaks of AChR/AChE/BuChE-aggregating  ac- 
tivity comigrate with polypeptides of 150 and 95 
kD; the  115- and 70-kD polypeptides do not ap- 
pear to possess any aggregating  activity. The cor- 
relation  between activity and the 95-kD polypep- 
tide is easily seen. We reached the conclusion that 
the 150-kD polypeptide is active and that the 115- 
kD polypeptide is probably inactive by comparing, 
for example, fractions 30 and 33. Each has a simi- 
lar amount of the 135-kD polypeptide,  yet fraction 
30 has readily detectable  activity and fraction 33 
has  no activity.  On the other hand,  the  150-kD 
polypeptide, like the activity, is present in fraction 
30 and  not detectable  in fraction 33.  Likewise, 
fractions 30 and 32 have comparable levels of ac- 
tivity and comparable levels of the  150-kD poly- 
peptide,  but very different  levels  of the  135-kD 
polypeptide. 
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others to extract basal lamina from kidney and blood vessels 
(26), was selected to provide a fraction enriched in compo- 
nents of  the extracellular matrix (16, 36). In initial reports we 
solubilized  agrin  from  the  extracellular  matrix-enriched 
fraction by treatment with high salt buffers (16); such buffers 
are known to solubilize another extracellular matrix-associ- 
ated molecule, acetylcholinesterase, from extracts of electric 
organ and muscle (21). We have now found, as indicated in 
our protocol, that agrin is more selectively and efficiently 
solubilized in 0.2 M bicarbonate buffer at pH 9. Although we 
recover >90 % of the AChR/AChE/BuChE-aggregating ac- 
tivity detected in the insoluble fraction in the pH 9 extract, 
we have recently found (unpublished observations) that re- 
peated extraction of the insoluble fraction can yield up to 
10-fold more agrin activity. Apparently most of the agrin in 
the insoluble fraction is bound to particulate material in such 
a way that its activity is not expressed in our in vitro assay 
and it is difficult to solubilize. 
We find that each of five different anti-agrin mAbs im- 
munoprecipitates polypeptides of 150-, 135-, 95-, and 70-kD 
from electric organ extracts; both the 150- and 95-kD poly- 
peptides have all three aggregating activities, while the 135- 
and 70-kD polypeptides are not active. A simple explanation 
for the existence of four agrin-related polypeptides is that the 
smaller are proteolytic fragments of the largest. We cannot 
rule out that some proteolysis occurs during our purification 
protocol, although care is taken to prepare extracts in the 
cold and in the presence of protease inhibitors. On the other 
hand, agrin may be a member of a family of antigenically, 
and perhaps functionally, related molecules that have a broad 
distribution in electric organ and muscle. Indeed, immuno- 
histochemical studies have shown that anti-agrin antibodies 
stain not only the synaptic basal lamina at the neuromuscular 
junction but also some of the basal lamina-coated surfaces 
of other structures in muscle and electric organ (15, 22, 34). 
Three polypeptides that cause up to a twofold increase in 
the number of AChR aggregates and a 1.4-6-fold increase in 
the rate of AChR insertion into the plasma membrane of cul- 
tured  myotubes have been  identified in  neural  tissues  by 
others. Any or all of these molecules may play a role in the 
formation of AChR aggregates at the neuromuscular junc- 
tion. They are a 42-kD polypeptide (ARIA) extracted from 
chick brain (42); an 84-kD polypeptide, called sciatin, which 
is extracted from sciatic nerves and is virtually identical to 
transferrin (e.g., reference 30); and calcitonin gene-related 
peptide, designated CGRP, which is 23 kD and is present in 
motor neurons (e.g., reference 28). The molecular mass of 
each clearly differs from that of the two forms of agrin. 
Moreover, agrin routinely causes a much more pronounced 
(up to 20-fold) increase in the number of receptor patches on 
myotubes and has little, if any, effect on the rate of receptor 
insertion (16). Thus, agrin is distinct from any of these mole- 
cules. Agrin also appears to be distinct from t~  molecules 
known to be concentrated in the synaptic cleft at the neuro- 
muscular junction and at the electric organ synapse: AChE 
and a heparan sulfate proteoglycan. For example, the molec- 
ular mass of the extracellular, An form of Torpedo  AChE is 
~106  D  (catalytic subunit:  monomer,  68  kD;  dimer,  131 
kD; tail subunit: 55 kD [19, 24]); the molecular mass of a 
heparan sulfate proteoglycan from the neuromuscular junc- 
tion is ,x,500 kD (3, 9) and that of an apparently similar mole- 
cule at synapses in the electric organ is  •106  D  (12).  The 
pattern of staining  seen with anti-agrin antibodies clearly 
distinguishes agrin from common basal lamina components 
such as laminin, type IV collagen, and entactin (34). On the 
other hand, agrin may be similar to as yet unidentified AChR- 
aggregating factors from rat brain (33), cultured embryonic 
neurons (38), neuronal cell lines (8), and rat diaphragm (7) 
which have apparent molecular masses of >50 kD. 
We are just beginning to examine how agrin causes the for- 
marion of AChR/AChE/BuChE  aggregates  (44).  We have 
shown that agrin-induced aggregation of AChRs occurs at 
least in part by lateral migration (16), as does nerve-induced 
AChR aggregation at developing neuromuscular junctions 
(2).  One way agrin could cause aggregation is by directly 
cross-linking AChR, ACHE, and BuChE molecules together, 
as is seen with antibody- and biotinylated e-bungarotoxin- 
avidin-induced AChR aggregation (5,  17). Such a  scheme 
would require ,~1 agrin molecule for each AChR, ACHE, and 
BuChE molecule in an aggregate. We estimated the amount 
of agrin in one unit of aggregating activity in two ways. First, 
we compared the intensity of staining of the 95-kD polypep- 
tide with that of BSA standards on silver-stained SDS-poly- 
acrylamide gels of immunoattinity-purified agrin (see Fig. 
6). This gave 1.2(+0.2)  x  10  -u g/U 95-kD agrin (mean + 
SEM; n =  8). A similar estimate was obtained by calculating 
the fraction of  the total radioactivity specifically immunopre- 
cipitated by anti-agrin mAbs from a ~25I-labeled  preparation 
of ion exchange pool (Fig. 4). Thus, in our muscle cultures 
agrin acts at ~10  't~ M. Extrapolating from the agrin-induced 
increase in the number of AChR aggregates per microscope 
field in our standard assay (16), we calculate that 1 U of agrin 
can induce as many as 1.5  x  105 patches, which is equiva- 
lent to 400 agrin molecules per patch. We can estimate the 
number of  AChRs per patch to be ,~64,000, based on an aver- 
age size of 16 gm  2 (unpublished observations) and a  con- 
centration of 4,000 AChRs/lim  2 in a  patch.  (We know of 
no direct measurement of the concentration of AChRs  in 
agrin-induced patches on chick myotubes: 2,000/gm  2 is the 
concentration seen in spontaneously occurring patches on 
rat myotubes; rat brain extract induces patches with  10,000 
AChRs/l~m 2 [37].) Thus, if every molecule of agrin added 
to a culture dish were bound in an aggregate, there would be 
at most 1 agrin for every 160 AChRs in each aggregate. Even 
if we have overestimated the specific activity of agrin and the 
number of AChRs in a patch each by a factor of four, there 
would still be at least a  10-fold excess of AChRs over agrin 
in a patch, not to mention an undetermined number of AChE 
and BuChE molecules. Therefore, it seems unlikely on nu- 
merical grounds that agrin induces aggregates by binding 
AChRs,  ACHE, and BuChE together, but rather that agrin 
acts either catalytically or by triggering some mechanism al- 
ready present in the myotube. For example, agrin could be 
an enzyme that causes AChRs, ACHE, and BuChE to aggre- 
gate spontaneously by modifying them or some other surface 
component to which they subsequently bind. In frog nerve- 
muscle cocultures, growing nerve terminals release a pro- 
teinase that degrades a heparan sulfate proteoglycan on the 
myotube surface; the removal of the heparan sulfate proteo- 
glycan is proposed to be an early step in neurite-induced 
AChR aggregation (1). Alternatively, agrin could bind to a 
receptor on the myotube surface that, in turn, initiates a cas- 
cade of events leading to AChR/AChE/BuChE aggregation. 
The Journal of Cell Biology, Volume 105, 1987  2476 Such a receptor-mediated mechanism might also be activated 
by nonphysiological signals, which would account for the ob- 
servation that positively charged latex beads induce the for- 
mation of specializations on cultured myotubes that resemble 
the postsynaptic apparatus (31). 
In  view  of the  constancy  of the postsynaptic  apparatus 
from embryo to adult and the reestablishment  of a  nearly 
identical  apparatus during regeneration  it is reasonable  to 
suggest that the same molecules that direct the formation of 
the postsynaptic apparatus during embryogenesis also main- 
tain  it  in  the  adult and direct  its  formation again  during 
regeneration.  Several  lines  of  evidence  indicate  that  the 
nerve terminal induces the formation of the postsynaptic ap- 
paratus during embryogenesis (13). Thus, it seems likely that 
the molecules that induce and maintain postsynaptic differ- 
entiation  are  synthesized  by  motor  neurons  and  released 
from their axon terminals.  We suggest that agrin is such a 
molecule  and present the following  hypothesis  for how it 
might act. As motor axons approach and grow over the sur- 
face of developing myofibers they release agrin.  Receptors 
for  agrin  are  scattered  over the  surface  of the  myotubes. 
When agrin binds to its receptor it causes AChRs, ACHE, 
BuChE,  and other components of the postsynaptic appara- 
tus, including components of the synaptic basal lamina,  to 
aggregate on the myotube surface in the vicinity of the acti- 
vated receptor.  (Indeed, a heparan sulfate proteoglycan [9], 
one component of basal  lamina,  accumulates  at agrin-in- 
duced AChR/AChE/BuChE  patches on cultured myotubes 
[unpublished observations]). Agrin becomes associated with 
this nascent synaptic basal lamina and thus is bound at the 
synaptic site. Such localization might have two consequences: 
(a) it might prolong the interaction of agrin with its receptor, 
and (b) it might prevent agrin from diffusing away from the 
synaptic  site  to  induce  unneeded  synaptic  specializations 
elsewhere  on  the  myofiber.  Release  of agrin  from  motor 
nerve terminals at the adult neuromuscular junction and its 
incorporation into the synaptic basal lamina would help main- 
tain the postsynaptic apparatus by insuring that newly syn- 
thesized  components become  concentrated  at the  synaptic 
site, while release of agrin by regenerating axons would ac- 
count for their ability to induce postsynaptic apparatus at ec- 
topic sites on denervated myofibers (e.g.,  reference 20). As 
we have previously suggested, agrin stably bound to the syn- 
aptic basal lamina at the adult neuromuscular junction would 
induce the aggregation of AChRs and AChE that occurs when 
myofibers regenerate  in the absence of nerve terminals  (4, 
25).  Consistent with our scheme is the finding that motor 
neurons contain agrin-like molecules: anti-agrin antibodies 
stain the cell bodies of embryonic and adult motor neurons 
and extracts of regions of the central nervous system rich in 
motor neurons contain molecules that are both antigenically 
similar to agrin and cause AChR aggregation on myofibers 
(40). 
This scheme does not eliminate the need for other factors 
that regulate the amount and turnover of molecules of the 
postsynaptic apparatus: for example, electromechanical  ac- 
tivity  (see reference  13) and molecules  such as the 42-kD 
polypeptide, ARIA, and the calcitonin gene-related peptide, 
designated CGRP. Nor does it obviate a role for components 
of the cytoskeleton, which may be linked to AChRs and thus 
could be  involved in the formation and/or  stabilization  of 
AChR aggregates (6, 10, 14, 32). Our hypothesis is that agrin 
triggers  the formation of the postsynaptic  apparatus  and 
specifies where on the myofiber it is to be assembled.  No 
doubt this simple scheme  will require modification as knowl- 
edge about synapse formation in general and agrin in particu- 
lar increases. Identifying agrin and developing antibodies to 
it, as reported here and in the accompanying  paper (34), are 
important steps toward making direct tests of  this hypothesis. 
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